A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1301 in Advanced Solid Tumors.
Clinical trial NCT06927349 · RECRUITING
Trial details
- NCT number
- NCT06927349
- Sponsor
- Shandong Boan Biotechnology Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-11
- Primary completion
- 2026-06-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.